Simian Hemorrhagic Fever (SHF) Virus. Phase 2.
Abstract
Phase II of this contract required that we develop and screen hybridoma cell lines which produce monoclonal antibodies specific for simian hemorrhagic fever (SHFV) virus.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 05, 1992
- Accession Number
- ADB167557
Entities
People
- Margo A. Brinton
Organizations
- Georgia State University